Spots Global Cancer Trial Database for Tobacco Treatment in the Context of Lung Cancer Screening

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Tobacco Treatment in the Context of Lung Cancer Screening

Official Title: Tobacco Treatment in the Context of Lung Cancer Screening

Study ID: NCT03927989

Conditions

Smoking Cessation

Interventions

Text messaging plus nicotine replacement therapy

Standard Care at Lung Cancer Screening

Study Description

Brief Summary: The proposed study will test a medication plus text messaging intervention specifically designed for lung cancer screening patients. Half of the patients will receive standard of care, and half will receive the treatment intervention.

Detailed Description: Screening for lung cancer at earlier, more treatable stages has the potential to reduce mortality from the U.S.'s most deadly cancer. Annual lung cancer screening with low-dose computed tomography is now recommended for high risk individuals based on age and smoking history. This study will evaluate a smoking cessation intervention for lung cancer screening patients. We will evaluate quit rates after a standard intervention (brief counseling session at time of lung cancer screening) versus a dual nicotine replacement therapy (NRT) and gain-framed text messaging intervention.